Iron deficiency is prevalent in patients with chronic kidney disease (CKD), and use of oral
and intravenous iron in patients with CKD who do not require dialysis might obviate or delay …

BACKGROUND: Iron supplementation is essential for the treatment of patients with anemia
of chronic kidney disease (CKD). It is not clear which is the best method of iron …

Iron deficiency is an important clinical concern in chronic kidney disease (CKD), giving rise
to iron-deficiency anemia and impaired cellular function. Oral supplementation, in particular …

Background: The management of iron-deficiency anaemia in patients with non-dialysis
chronic kidney disease (ND-CKD) remains controversial, particularly regarding the use of …

Patients with chronic kidney disease (CKD), especially those requiring maintenance
hemodialysis treatments, may lose up to 3 g of iron each year because of frequent blood …

Background: Availability of recombinant human erythropoietin (rHuEPO) has improved the
treatment of anemia due to chronic kidney disease (CKD). Iron deficiency is the most …

Background: It is unknown whether intravenous iron or oral iron repletion alone can correct
anemia associated with chronic kidney disease (CKD). We conducted a randomized …

The results of recent randomized, controlled trials in patients with chronic kidney disease
and anemia have suggested that hyporesponsiveness to erythropoiesis stimulating agents …

Controversies in iron management. Background Iron therapy is required in hemodialysis
patients receiving erythropoietic stimulators in order to achieve the target hemoglobin in the …

Anemia is a common complication in patients with chronic kidney disease (CKD), mainly
due to inadequate renal production of erythropoietin. In hemodialysis (HD) patients this …